TheEdgeResearch
Home / Stocks / TCCR

TRICCAR, Inc. (TCCR)

OTC Healthcare Biotechnology
$1.50 ▲ +23.97%
Market Cap
$0
Sector
Healthcare
Industry
Biotechnology
Beta
-0.07
52-Wk Range
1.5-1.6
CEO
Country
US
Currency
USD

TRICCAR, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Shreveport, LA, US. The stock last traded at $1.50, up 23.97% on the session, giving a market capitalisation of $0. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -169.1%. Its beta of -0.07 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
-0.00
EV / EBITDA
-0.37
Gross margin
18.3%
Operating margin
-82.2%
Net margin
-169.1%
Return on equity
Debt / equity
-1.14
Current ratio
0.42
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
IPO date
2021-12-23
Headquarters
Shreveport, LA, US
About TRICCAR, Inc.

TRICCAR, Inc. delivers essential saltwater disposal services, primarily catering to the oil and gas industry. The company supports hydrocarbon producers by providing a crucial solution for managing the saline wastewater that results from their extraction operations. All disposal activities take place at specialized wells situated in Wise County, Texas, while TRICCAR's corporate base is located in Shreveport, Louisiana.

Comparable companies

TRICCAR, Inc. is most often compared with the following Healthcare names:

BSTGDMTTFHITCHRPMFMCIOFMSSTFMVRBFNEVPFONPPFRLFTD
More research on TCCR
TCCR technical analysis TCCR TheEdge Score Compare against peers
Open full interactive analysis & DCF →